HomeOpen Access NewsAlzheimer's Disease

Alzheimer's Disease

How toxic tau spreads in progressive supranuclear palsy: New research reveals synaptic link

UK Dementia Research Institute scientists reveal how toxic tau spreads between neurons in PSP, causing synapse loss.

Dementia as a progressive condition

The Alzheimer's Society in the UK provides a fascinating glimpse into the most dementia as a progressive condition and its common forms

Can a new light-based therapy help with Alzheimer’s disease?

Prof Michael R Hamblin of the Wellman Center for Photomedicine at Massachusetts General Hospital discusses a new light-based therapy for Alzheimer’s disease

Finding effective treatments for vascular dementia

Dr Doug Brown, Director of Research, Alzheimer’s Society provides details on the research into vascular dementia and explains why more work is needed Vascular dementia...

Tackling cognitive decline in Alzheimer’s disease

Ai-Ling Lin PhD, of The Lin Brain Lab talks about the reversal of cognitive decline in Alzheimer’s disease with comprehensive and personalised nutrition Alzheimer’s disease...

Pharmacogenomics of polypharmacy in Alzheimer’s disease

Ramón Cacabelos of EuroEspes Biomedical Research Center details how the incorporation of pharmacogenomics to treat Alzheimer’s patients is crucial

Dementia research: Translating knowledge into new treatments

Chief Executive Hilary Evans highlights how Alzheimer’s Research UK is helping advance dementia research, but warns there is still more to be done

Italy’s ageing population and the healthcare challenge

Open Access Government examines some of the statistics around Italy's ageing population, related health challenges, and policy action to address the issue Italy is currently...

Making personal budgets dementia friendly

A sea change is needed among local authorities to make personal budgets dementia friendly, argues George McNamara of the Alzheimer’s Society People with dementia and...

The role of small heat shock proteins in human diseases

Professor Serena Carra and her collaborators are investigating the important role of small heat shock proteins in age-related neurodegenerative diseases Cells are frequently exposed to...

Time for a change of tack on drug development for neurodegenerative diseases?

UCB's Duncan McHale outlines why reclassification might be a good idea to boost drug development for neurodegenerative diseases like Alzheimer's and Parkinson's Neurodegenerative diseases are...

Nanoimaging to cure Alzheimer’s disease

Background of Alzheimer’s disease Alzheimer’s disease (AD) is one of the most devastating neurodegenerative disorders affecting more than 25 million people worldwide which is the...

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders